Cesar A Migliorati, DDS, MS, PhD
Professor, Oral Medicine
Department:
DN-ORAL MEDICINE
Business Phone:
(352) 294-5576
Business Email:
cmigliorati@dental.ufl.edu
About Cesar A Migliorati
Now a professor in the Department of Oral & Maxillofacial Diagnostic Sciences, Migliorati served as associate dean for Clinical Affairs and Quality at UFCD from 2017 until March 2021.
In a year that challenged the nation and world, and especially those on the front lines in health care, Migliorati played a crucial role in the UFCD response to the COVID-19 pandemic, coordinating efforts with UF Health experts in infection control and epidemiology, assuring access to personal protective equipment for dental students, providers and staff, and putting in place new infection control protocols.
In May 2019, Migliorati was appointed president of the American Board of Oral Medicine and subsequently served a one-year term in the role.
During his four years as associate dean, Migliorati made important and lasting contributions to the college and broader community. In addition to a wealth of experience and insights, and applied a data-driven approach to make meaningful enhancements to UFCD patient care, safety and quality.
Under his leadership and with great support from his team, the college reorganized its clinical administration to improve workflow and efficiency. Working closely with Luisa Echeto, D.D.S., M.S., and other colleagues, Migliorati implemented a new DMD-patient screening process to standardize patient selection and centralized sterilization processes to enhance quality.
His current research collaborations focus on supportive care in cancer and the oral complications of cancer therapy. Migliorati also has a comprehensive clinical background, having worked in clinical dentistry during his entire career both academically and in private practice.
Teaching Profile
Courses Taught
2017-2018,2020
DEN7016 Prof Care/Prac Man 2
2020
DEN7761L Oral Dx/Med Treat 1
2017-2018,2020
DEN7017 Prof Care/Prac Man 3
2020
DEN8018 Prof Care/Prac Man 4
2018
DEN5010 Interdis Serv Learn 1
2017
DEN5013 Found Professionalism
2021
DEN8290 Special Topics
2021-2024
DEN7012 Service Learning 3
Board Certifications
-
Oral MedicinistAmerican Board of Oral Medicine
Clinical Profile
Specialties
- Dentistry
- Oral Medicine
Areas of Interest
- Oral cancer
- Osteonecrosis
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0002-2535-2606
Areas of Interest
- Medication-related osteonecrosis of the jaw
- Oral cancer
- Oral complications of cancer therapy
- Oral medicine
- Oral mucosal lesions
- Targeted Cancer Therapy
- lasers in dentistry
Publications
2024
Chronic oral diseases secondary to COVID-19 infection or vaccination: clinical cases and a narrative review.
Quintessence international (Berlin, Germany : 1985).
[DOI] 10.3290/j.qi.b5031811.
[PMID] 38415994.
2024
Integrating e-cigarette (vaping) questions into medical and dental charts: a critical need.
Oral surgery, oral medicine, oral pathology and oral radiology.
137(2):93-94
[DOI] 10.1016/j.oooo.2023.10.007.
[PMID] 38114404.
2024
Patient communication protocols for sexually transmitted infections: A systematic review
Special Care in Dentistry.
[DOI] 10.1111/scd.12976.
2023
Can the prophylactic use of pentoxifylline and tocopherol before dental extractions prevent osteoradionecrosis? A systematic review.
Oral surgery, oral medicine, oral pathology and oral radiology.
136(1):33-41
[DOI] 10.1016/j.oooo.2023.01.005.
[PMID] 36882364.
2023
Clinical and Psychosocial Impact of Communication about Oral Potentially Malignant Disorders: A Scoping Review.
Dentistry journal.
11(9)
[DOI] 10.3390/dj11090209.
[PMID] 37754329.
2023
Clinical outcomes of dental implants in head and neck cancer patients: An overview.
Oral surgery, oral medicine, oral pathology and oral radiology.
136(1):42-53
[DOI] 10.1016/j.oooo.2023.01.006.
[PMID] 36890080.
2023
Corrigendum to ‘Clinical outcomes of dental implants in head and neck cancer patients: An overview’.
Oral surgery, oral medicine, oral pathology and oral radiology.
136(5)
[DOI] 10.1016/j.oooo.2023.07.014.
[PMID] 37516619.
2023
Corrigendum to Twenty-year analysis of clinic studies of photobiomodulation for oral mucositis: a scoping review, Oral Surg Oral Med Oral Pathol Oral Radiol. 135 (2023) 626-641.
Oral surgery, oral medicine, oral pathology and oral radiology.
136(4):529-530
[DOI] 10.1016/j.oooo.2023.06.007.
[PMID] 37516621.
2023
Machine learning for the prediction of toxicities from head and neck cancer treatment: A systematic review with meta-analysis.
Oral oncology.
140
[DOI] 10.1016/j.oraloncology.2023.106386.
[PMID] 37023561.
2023
Patient’s perceptions of oral and oropharyngeal cancer diagnosis disclosure: communication aspects based on SPIKES protocol.
Oral surgery, oral medicine, oral pathology and oral radiology.
135(4):518-529
[DOI] 10.1016/j.oooo.2022.12.008.
[PMID] 36740563.
2023
The barriers dentists face to communicate cancer diagnosis: self-assessment based on SPIKES protocol.
Medicina oral, patologia oral y cirugia bucal.
28(2):e191-e198
[DOI] 10.4317/medoral.25650.
[PMID] 36565222.
2023
The Intersectionality between Race, Ethnicity, and Residential-Level Socioeconomic Status in Disparities of Head and Neck Cancer Outcomes: A SEER Study
Cancer Epidemiology, Biomarkers & Prevention.
32(4):516-523
[DOI] 10.1158/1055-9965.epi-22-1167.
2023
Twenty-year analysis of photobiomodulation clinical studies for oral mucositis: a scoping review.
Oral surgery, oral medicine, oral pathology and oral radiology.
135(5):626-641
[DOI] 10.1016/j.oooo.2022.12.010.
[PMID] 36870898.
2022
Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis.
Oral surgery, oral medicine, oral pathology and oral radiology.
134(5):573-587
[DOI] 10.1016/j.oooo.2022.07.006.
[PMID] 36153299.
2022
Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial
Supportive Care in Cancer.
30(3):2225-2236
[DOI] 10.1007/s00520-021-06625-8.
[PMID] 34708311.
2022
Oral Complications in Cancer Patients-Medication-Related Osteonecrosis of the Jaw (MRONJ).
Frontiers in oral health.
3
[DOI] 10.3389/froh.2022.866871.
[PMID] 35558547.
2022
Oral medicine (stomatology) in Brazil: the first 50 years and counting.
Oral surgery, oral medicine, oral pathology and oral radiology.
134(1):57-64
[DOI] 10.1016/j.oooo.2022.01.018.
[PMID] 35331676.
2022
Over 300 Radiation Caries Papers: Reflections From the Rearview Mirror.
Frontiers in oral health.
3
[DOI] 10.3389/froh.2022.961594.
[PMID] 35911379.
2022
Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.
Frontiers in oncology.
12
[DOI] 10.3389/fonc.2022.927685.
[PMID] 36110957.
2022
State-of-the-science concepts of HPV-related oropharyngeal squamous cell carcinoma: a comprehensive review.
Oral surgery, oral medicine, oral pathology and oral radiology.
134(2):190-205
[DOI] 10.1016/j.oooo.2022.03.016.
[PMID] 35725962.
2021
Adalimumab-induced sarcoidosis-like reaction involving oral cavity in rheumatoid arthritis: a case-based review
Clinical Rheumatology.
[DOI] 10.1007/s10067-021-05654-2.
2021
Awareness of the risk of radiation-related caries in patients with head and neck cancer: A survey of physicians, dentists, and patients
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.
132(4):398-408
[DOI] 10.1016/j.oooo.2021.06.011.
2021
Cilostazol and Tocopherol in the Management of Medication-Related Osteonecrosis of the Jaw: New Insights From a Case Report.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
79(12):2499-2506
[DOI] 10.1016/j.joms.2021.06.036.
[PMID] 34339622.
2021
Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).
EClinicalMedicine.
31
[DOI] 10.1016/j.eclinm.2020.100693.
[PMID] 33554084.
2021
Correction to: Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
29(7)
[DOI] 10.1007/s00520-021-06249-y.
[PMID] 33913008.
2021
Cost-effectiveness of photobiomodulation therapy for the prevention and management of cancer treatment toxicities: a systematic review
Supportive Care in Cancer.
29(6):2875-2884
[DOI] 10.1007/s00520-020-05949-1.
2021
Direct costs associated with the management of mucositis: A systematic review.
Oral oncology.
118
[DOI] 10.1016/j.oraloncology.2021.105296.
[PMID] 33933777.
2021
Is medication-related osteonecrosis of the jaw associated with tumor necrosis factor-α inhibition?
Oral surgery, oral medicine, oral pathology and oral radiology.
131(4):422-427
[DOI] 10.1016/j.oooo.2020.12.001.
[PMID] 33408034.
2021
Long-term safety of photobiomodulation therapy for oral mucositis in hematopoietic cell transplantation patients: a 15-year retrospective study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
29(11):6891-6902
[DOI] 10.1007/s00520-021-06268-9.
[PMID] 34021422.
2021
Oral care and photobiomodulation protocol for the prevention of traumatic injuries and lip necrosis in critically ill patients with COVID-19: an observational study.
Lasers in dental science.
5(4):239-245
[DOI] 10.1007/s41547-021-00144-9.
[PMID] 34816005.
2021
Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ?
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.
131(2):e45-e51
[DOI] 10.1016/j.oooo.2020.07.014.
[PMID] 32888876.
2021
Reply: Insights and challenges in the management of oral lesions in patients with COVID-19.
Oral surgery, oral medicine, oral pathology and oral radiology.
132(1):120-121
[DOI] 10.1016/j.oooo.2021.01.026.
[PMID] 34022767.
2021
Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment–induced severe oral mucositis
Supportive Care in Cancer.
29(6):2939-2946
[DOI] 10.1007/s00520-020-05805-2.
2021
Strategic use of obturator prostheses for the rehabilitation of oral cancer patients during the COVID-19 pandemic
Supportive Care in Cancer.
29(1):11-15
[DOI] 10.1007/s00520-020-05694-5.
[PMID] 32856215.
2021
Successful denosumab treatment for central giant cell granuloma in a 9‐year‐old child
Special Care in Dentistry.
41(4):519-525
[DOI] 10.1111/scd.12588.
2020
Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents.
Oral diseases.
26(5):955-966
[DOI] 10.1111/odi.13294.
[PMID] 32011077.
2020
Antimicrobial photodynamic and photobiomodulation adjuvant therapies for prevention and treatment of medication-related osteonecrosis of the jaws: Case series and long-term follow-up.
Photodiagnosis and photodynamic therapy.
29
[DOI] 10.1016/j.pdpdt.2020.101651.
[PMID] 31923636.
2020
Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
28(10):4545-4548
[DOI] 10.1007/s00520-020-05636-1.
[PMID] 32696245.
2020
Laser excision of oral leukoplakia: Does it affect recurrence and malignant transformation? A systematic review and meta-analysis.
Oral oncology.
109
[DOI] 10.1016/j.oraloncology.2020.104850.
[PMID] 32540612.
2020
Safety and efficacy of photobiomodulation therapy in oncology: A systematic review.
Cancer medicine.
9(22):8279-8300
[DOI] 10.1002/cam4.3582.
[PMID] 33107198.
2020
Severe oral erosive lichenoid reaction to pembrolizumab therapy.
Oral surgery, oral medicine, oral pathology and oral radiology.
130(5):e301-e307
[DOI] 10.1016/j.oooo.2020.06.014.
[PMID] 32654932.
2020
The impact of radiation caries in the quality of life of head and neck cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
28(6):2977-2984
[DOI] 10.1007/s00520-019-05171-8.
[PMID] 31773272.
2019
A Severe, Refractory Case of Mucous Membrane Pemphigoid After Treatment With Pembrolizumab: Brief Communication.
Journal of immunotherapy (Hagerstown, Md. : 1997).
42(9):359-362
[DOI] 10.1097/CJI.0000000000000280.
[PMID] 31246641.
2019
Examining tumor modulating effects of photobiomodulation therapy on head and neck squamous cell carcinomas.
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
18(7):1621-1637
[DOI] 10.1039/c9pp00120d.
[PMID] 31197302.
2019
Is photobiomodulation therapy effective in reducing pain caused by toxicities related to head and neck cancer treatment? A systematic review.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
27(11):4043-4054
[DOI] 10.1007/s00520-019-04939-2.
[PMID] 31264186.
2019
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
37(25):2270-2290
[DOI] 10.1200/JCO.19.01186.
[PMID] 31329513.
2019
Medication-Related Osteonecrosis of the Jaws.
Journal of the National Cancer Institute. Monographs.
2019(53)
[DOI] 10.1093/jncimonographs/lgz009.
[PMID] 31425596.
2019
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
27(2):383-394
[DOI] 10.1007/s00520-018-4501-x.
[PMID] 30353228.
2019
Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
27(10):3969-3983
[DOI] 10.1007/s00520-019-04890-2.
[PMID] 31286228.
2018
Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
26(7):2417-2423
[DOI] 10.1007/s00520-018-4046-z.
[PMID] 29423682.
2018
Osteonecrosis of the jaw (ONJ) in patients who receive Bone Targeting Agents (BTAs): the power of e-learning.
Ecancermedicalscience.
12
[DOI] 10.3332/ecancer.2018.ed77.
[PMID] 29456623.
2018
Panoramic and skull imaging may aid in the identification of multiple myeloma lesions.
Medicina oral, patologia oral y cirugia bucal.
23(1):e38-e43
[DOI] 10.4317/medoral.22123.
[PMID] 29274154.
2018
Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates.
Journal of the American Dental Association (1939).
149(5):382-391
[DOI] 10.1016/j.adaj.2017.12.028.
[PMID] 29703280.
2017
Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis.
Cancer medicine.
6(12):2918-2931
[DOI] 10.1002/cam4.1221.
[PMID] 29071801.
2016
Comparison of mandibular cortical thickness and QCT-derived bone mineral density (BMD) in survivors of childhood acute lymphoblastic leukemia: a retrospective study.
International journal of paediatric dentistry.
26(5):330-5
[DOI] 10.1111/ipd.12203.
[PMID] 26370921.
2016
Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
24(6):2781-92
[DOI] 10.1007/s00520-016-3152-z.
[PMID] 26984240.
2016
Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
24(6):2793-805
[DOI] 10.1007/s00520-016-3153-y.
[PMID] 26984249.
2016
RE: Regorafenib Also Can Cause Osteonecrosis of the Jaw.
Journal of the National Cancer Institute.
108(9)
[DOI] 10.1093/jnci/djw155.
[PMID] 27390045.
2015
Dental demineralization and caries in patients with head and neck cancer.
Oral oncology.
51(9):824-31
[DOI] 10.1016/j.oraloncology.2015.06.009.
[PMID] 26198979.
2015
Development of tools for the oral health and panoramic radiograph evaluation of head and neck cancer patients: a methodological study.
Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
35(5):243-252
[DOI] 10.1111/scd.12125.
[PMID] 26178803.
2015
Experience and expertise regarding orthodontic management of childhood and adolescent cancer survivors.
American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.
148(5):765-70
[DOI] 10.1016/j.ajodo.2015.05.027.
[PMID] 26522036.
2015
Oral Complications of Cancer Therapy: A Summary Guide for the Clinician.
The Journal of the Tennessee Dental Association.
95(1):24-32; quiz 33
[PMID] 26434000.
2015
Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review.
Oral surgery, oral medicine, oral pathology and oral radiology.
120(6):699-706
[DOI] 10.1016/j.oooo.2015.08.007.
[PMID] 26455289.
2014
Associations of oral health items of the Vanderbilt Head and Neck Symptom Survey with a dental health assessment.
Oral oncology.
50(2):135-40
[DOI] 10.1016/j.oraloncology.2013.10.019.
[PMID] 24239279.
2014
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Cancer.
120(10):1453-61
[DOI] 10.1002/cncr.28592.
[PMID] 24615748.
2014
Oral and dental late effects in survivors of childhood cancer: a Children’s Oncology Group report.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
22(7):2009-19
[DOI] 10.1007/s00520-014-2260-x.
[PMID] 24781353.
2014
The intersection of oral medicine and interprofessional education.
Oral surgery, oral medicine, oral pathology and oral radiology.
117(6):787-90
[DOI] 10.1016/j.oooo.2014.03.002.
[PMID] 24842450.
2013
Assessing the association between bisphosphonate exposure and delayed mucosal healing after tooth extraction.
Journal of the American Dental Association (1939).
144(4):406-14
[PMID] 23543695.
2013
Can dental students be taught to use dental radiographs for osteoporosis screening?
Journal of dental education.
77(5):598-603
[PMID] 23658405.
2013
Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
21(1):333-41
[DOI] 10.1007/s00520-012-1605-6.
[PMID] 23001179.
2011
Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs.
Journal of the American Dental Association (1939).
142(11):1243-51
[PMID] 22041409.
2011
Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review.
Nature reviews. Endocrinology.
7(1):34-42
[DOI] 10.1038/nrendo.2010.195.
[PMID] 21079615.
2011
Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
112(2):195-202
[DOI] 10.1016/j.tripleo.2011.02.037.
[PMID] 21622014.
2010
A systematic review of bisphosphonate osteonecrosis (BON) in cancer.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
18(8):1099-106
[DOI] 10.1007/s00520-010-0882-1.
[PMID] 20411279.
2010
Commentary: Massive osteolysis or Gorham-Stout disease.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
109(2):242-3
[DOI] 10.1016/j.tripleo.2009.09.030.
[PMID] 20123408.
2010
How patients’ lack of knowledge about oral bisphosphonates can interfere with medical and dental care.
Journal of the American Dental Association (1939).
141(5):562-6
[PMID] 20436104.
2010
Osteonecrosis of the jaws induced by drugs other than bisphosphonates – a call to update terminology in light of new data.
Oral oncology.
46(1)
[DOI] 10.1016/j.oraloncology.2009.10.004.
[PMID] 19932046.
2009
Bisphosphonate osteonecrosis (BON): unanswered questions and research possibilities.
Reviews on recent clinical trials.
4(2):99-109
[PMID] 19463106.
2009
Low incidence of osteonecrosis of the jaw in postmenopausal women with osteoporosis taking zoledronic acid once yearly.
The journal of evidence-based dental practice.
9(1):13-5
[DOI] 10.1016/j.jebdp.2008.12.014.
[PMID] 19269608.
2009
New oncology drugs and osteonecrosis of the jaw (ONJ).
The Journal of the Tennessee Dental Association.
89(4):36-8; quiz 38
[PMID] 20102031.
2008
Dental management of patients with a history of bisphosphonate therapy: clinical dilemma.
Journal of the California Dental Association.
36(10):769-74
[PMID] 19044097.
2008
Intravenous bisphosphonate therapy may lead to osteonecrosis of the jaw in multiple myeloma, breast, and prostate cancer patients.
The journal of evidence-based dental practice.
8(2):93-4
[DOI] 10.1016/j.jebdp.2008.03.018.
[PMID] 18492584.
2008
Oral osteonecrosis associated with the use of ibandronate: report of a case and clinical implications.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
106(1):e18-21
[DOI] 10.1016/j.tripleo.2008.03.005.
[PMID] 18585606.
2008
Osteoporosis and its implications for dental patients.
Journal of the American Dental Association (1939).
139(5):545-52; quiz 625
[PMID] 18451370.
2008
Periodontal diseases and cancer.
The Lancet. Oncology.
9(6):510-2
[DOI] 10.1016/S1470-2045(08)70138-4.
[PMID] 18510985.
2008
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.
The Lancet. Oncology.
9(12):1166-72
[DOI] 10.1016/S1470-2045(08)70305-X.
[PMID] 19038763.
2008
Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs.
Journal of the American Dental Association (1939).
139(12):1674-7
[PMID] 19047674.
2007
A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
15(10):1145-54
[PMID] 17393191.
2007
Exposed bone in the palate.
Journal of the American Dental Association (1939).
138(10):1341-3
[PMID] 17908847.
2007
Management of oral epithelial dysplasia: a review.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
103 Suppl:S19.e1-12
[PMID] 17257863.
2007
Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
103 Suppl:S25.e1-12
[PMID] 17261375.
2007
Oral manifestations of Wegener’s granulomatosis: a report of three cases and a literature review.
Journal of the American Dental Association (1939).
138(3):338-48; quiz 396, 398
[PMID] 17332039.
2007
Osteonecrosis of the jaw may not be a common acute side-effect of oral bisphosphonates.
The journal of evidence-based dental practice.
7(2):77-8
[PMID] 17599658.
2007
Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
Critical reviews in oncology/hematology.
64(3):198-207
[PMID] 17855108.
2007
The interface between oral and systemic health: the need for more collaboration.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
13 Suppl 4:11-6
[PMID] 17716291.
2007
Treatment of bisphosphonates-associated osteonecrosis.
Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.
4(1):62-8
[PMID] 22460756.
2007
Updated clinical practice guidelines for the prevention and treatment of mucositis.
Cancer.
109(5):820-31
[PMID] 17236223.
2006
Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.
The Lancet. Oncology.
7(6):508-14
[PMID] 16750501.
2006
Bisphosphonates are associated with the development of exposed bone (osteonecrosis/osteopetrosis) in the oral cavity.
The journal of evidence-based dental practice.
6(4):283-4
[PMID] 17174254.
2006
Promulgation of guidelines for mucositis management: educating health care professionals and patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
14(6):548-57
[PMID] 16775650.
2006
The role of alternative and natural agents, cryotherapy, and/or laser for management of alimentary mucositis.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
14(6):533-40
[PMID] 16572313.
2005
Bisphosphonate-associated oral osteonecrosis.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
99(2)
[PMID] 15660080.
2005
Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Cancer.
104(1):83-93
[PMID] 15929121.
2005
Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper.
Journal of the American Dental Association (1939).
136(12):1658-68
[PMID] 16383047.
2004
Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
98(3):301-10
[PMID] 15356467.
2003
Bisphosphanates and oral cavity avascular bone necrosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
21(22):4253-4
[PMID] 14615459.
1997
Oral lesions and HIV. An approach to the diagnosis of oral mucosal lesions for the dentist in private practice.
Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia.
107(10):860-71
[PMID] 9360440.
1995
Oral cytology: indications, contraindications, and technique.
General dentistry.
43(1):74-7; quiz 79
[PMID] 7758928.
1995
Oral histoplasmosis in HIV-infected patients. A report of two cases.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
79(6):710-4
[PMID] 7621028.
1994
Percutaneous and mucous membrane exposure protocol in a southeastern dental school.
Oral surgery, oral medicine, and oral pathology.
78(3):401-7
[PMID] 7970606.
1994
The Cytobrush Plus cell collector in oral cytology.
Oral surgery, oral medicine, and oral pathology.
77(1):95-9
[PMID] 8108108.
1993
Use of exfoliative cytology in the diagnosis of oral hairy leukoplakia.
Oral surgery, oral medicine, and oral pathology.
76(6):704-10
[PMID] 7506822.
1992
Reactivity of monoclonal antibodies 17.13 and 63.12 with 141 oral mucosal lesions.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
21(9):412-7
[PMID] 1279163.
1992
The simultaneous occurrence of oral herpes simplex virus, cytomegalovirus, and histoplasmosis in an HIV-infected patient.
Oral surgery, oral medicine, and oral pathology.
74(3):334-9
[PMID] 1328984.
1992
Toluidine blue staining and early detection of oral precancerous and malignant lesions.
The Iowa dental journal.
78(2):15-6
[PMID] 1628933.
1990
Findings in 50 AIDS virus-infected patients with positive oral Candida cultures.
The Journal of the Dental Association of Thailand.
40(4):157-64
[PMID] 2074328.
1990
Use of monoclonal antibody 17.13 in the diagnosis of human oral squamous cell carcinoma.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
19(9):414-8
[PMID] 1702836.
1989
Chemotherapeutic mouthrinses in immunocompromised patients.
American journal of dentistry.
2 Spec No:303-7
[PMID] 2700644.
1988
Kaposi’s sarcoma of the oral cavity: a study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects, and treatment.
Oral surgery, oral medicine, and oral pathology.
66(5):543-50
[PMID] 3059252.
1986
Oral findings in people with or at high risk for AIDS: a study of 375 homosexual males.
Journal of the American Dental Association (1939).
112(2):187-92
[PMID] 3485126.
1986
Phenotypic identification of mononuclear cells in oral premalignant lesions and cancer by monoclonal antibodies.
Journal of oral pathology.
15(6):352-8
[PMID] 3093654.
1985
Clinical efficacy of prednisone in the treatment of patients with oral inflammatory ulcerative diseases: a study of fifty-five patients.
Oral surgery, oral medicine, and oral pathology.
59(4):360-3
[PMID] 3858773.
1985
Localization of basement membrane components in mucous membrane pemphigoid.
The Journal of investigative dermatology.
84(2):105-7
[PMID] 3881535.
1984
[Acquired immune deficiency syndrome (AIDS)].
Revista da Associacao Paulista de Cirurgioes Dentistas.
38(5):351-2, 355
[PMID] 6599139.
1984
Adverse side effects associated with prednisone in the treatment of patients with oral inflammatory ulcerative diseases.
Journal of the American Dental Association (1939).
109(2):269-70
[PMID] 6590608.
1984
The diagnosis of AIDS and AIDS related complex in the dental office: findings in 171 homosexual males.
CDA journal.
12(6):21-5
[PMID] 6590130.
1984
Toluidine blue staining in the detection of oral precancerous and malignant lesions.
Oral surgery, oral medicine, and oral pathology.
57(4):379-82
[PMID] 6200814.
1983
Current assessment; dental risks and guidelines in the AIDS epidemic.
CDA journal.
11(10):7-10
[PMID] 6233014.
1983
Oral manifestations of tumor and opportunistic infections in the acquired immunodeficiency syndrome (AIDS): findings in 53 homosexual men with Kaposi’s sarcoma.
Oral surgery, oral medicine, and oral pathology.
56(5):491-4
[PMID] 6580594.
Grants
Aug 2023
ACTIVE
Photobiomodulation for the management of Temporomandibular disorder pain
Role: Co-Investigator
Funding: NATL INST OF HLTH NIDCR
Jul 2022
– Jul 2023
Photobiomodulation for the management of Temporomandibular disorder pain
Role: Co-Investigator
Funding: NATL INST OF HLTH NIDCR
Contact Details
Phones:
- Business:
- (352) 294-5576
Emails:
- Business:
- cmigliorati@dental.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100412
GAINESVILLE FL 32610 - Business Street:
-
1395 CENTER DR RM D8 28
GAINESVILLE FL 32610